Abstract
Background: Various allergenic proteins are produced by house dust mites (HDM). However, the allergenicity and clinical implications of these allergens are unknown. Objective: The purpose of this study was to identify allergens in Dermatophagoides farinae and elucidate the sensitization profiles to these in Korean patients suffering from respiratory (allergic rhinitis and/or asthma) and atopic dermatitis symptoms. Methods: IgE reactivities in sera from 160 HDM allergy patients were analysed by one- and two-dimensional gel electrophoresis and immunoblotting. IgE-reactive components were identified by liquid chromatography-coupled electrospray ionization-tandem mass spectrometry. Nine recombinant mite allergens (Der f 1, Der f 2, Der f 10, Der f 11, Der f 13, Der f 14, Der f 30, Der f 32 and Der f Alt a 10) were produced, and the IgE reactivity in sera to each was determined by ELISAs. Results: Der f 1 and Der f 2 were recognized by IgE in serum samples from 88.1% and 78.1% of all patients, respectively. Patients with respiratory allergies were mainly sensitized to these major allergens, whereas patients with atopic dermatitis symptoms showed polysensitization to major and minor allergen components (including Der f 11, Der f 13, Der f 14, Der f 32 and Der f Alt a 10). Conclusions: Patients with respiratory allergic disease sensitize to major allergen components of HDM. Those with atopic dermatitis were sensitized to a broader range of minor allergen components of HDM (Der f 11, Der f 13, Der f 14, Der f 32 and Der f Alt a 10).
Original language | English |
---|---|
Pages (from-to) | 1050-1058 |
Number of pages | 9 |
Journal | Clinical and Experimental Allergy |
Volume | 48 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2018 Aug |
Bibliographical note
Funding Information:This work was supported by funding from the Korean Academy of Asthma, Allergy and Clinical Immunology (to KH Park) and from the Korea Health Technology R&D Project, funded by Ministry of Health & Welfare, Korea (no. HI13C0010 and HI14C1324 to J-W Park)
Funding Information:
Funding information This work was supported by funding from the Korean Academy of Asthma, Allergy and Clinical Immunology (to KH Park) and from the Korea Health Technology R&D Project, funded by Ministry of Health & Welfare, Korea (no. HI13C0010 and HI14C1324 to J-W Park)
Publisher Copyright:
© 2018 John Wiley & Sons Ltd
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology